Rodriguez-Abreu D, Bosch-Barrera J, Gray JE, Ahn MJ, et al. STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations. Clin Lung Cancer 2024 Jan 6:S1525-7304(23)00267.
PMID: 38310035